Compare BAC & PM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BAC | PM |
|---|---|---|
| Founded | 1784 | 1987 |
| Country | United States | United States |
| Employees | 213000 | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 380.6B | 277.9B |
| IPO Year | N/A | 2007 |
| Metric | BAC | PM |
|---|---|---|
| Price | $63.13 | $189.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 9 |
| Target Price | $60.34 | ★ $189.78 |
| AVG Volume (30 Days) | ★ 30.6M | 5.1M |
| Earning Date | 04-15-2026 | 04-22-2026 |
| Dividend Yield | 2.12% | ★ 3.61% |
| EPS Growth | N/A | ★ 60.62 |
| EPS | N/A | ★ 3.36 |
| Revenue | N/A | ★ $40,648,000,000.00 |
| Revenue This Year | $13.11 | $10.54 |
| Revenue Next Year | $5.80 | $6.65 |
| P/E Ratio | ★ $14.01 | $55.97 |
| Revenue Growth | N/A | ★ 7.31 |
| 52 Week Low | $45.81 | $142.11 |
| 52 Week High | $63.97 | $207.76 |
| Indicator | BAC | PM |
|---|---|---|
| Relative Strength Index (RSI) | 65.95 | 49.91 |
| Support Level | $51.20 | $172.68 |
| Resistance Level | N/A | $190.25 |
| Average True Range (ATR) | 1.02 | 5.28 |
| MACD | -0.06 | -0.95 |
| Stochastic Oscillator | 75.16 | 15.77 |
Bank of America is a formidable financial titan with a $3.5 trillion balance sheet and a cornerstone of the American economy, holding the second-largest deposit market share in the United States. While the firm has maintained its stronghold among middle-market and retail clientele domestically, Bank of America has continued to hold its own on the global stage, as evidenced by its fourth-largest global trading operation and an investment banking division that regularly finishes in the top four in global league tables. The firm is organized across four segments: consumer banking, global wealth and investment management, global banking, and global markets.
Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heat sticks, vapes, and oral nicotine offerings, primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI is not only dominant in smokable products but also has the Iqos and Zyn brands, which respectively dominate heated tobacco and nicotine pouches in most markets. It also owns the Veev brand in vapes.